March 11, 2008 - AutoPulse Units Purchased by French Fire Brigade from ZOLL


A. Ernest Whiton
Chief Financial Officer
ZOLL Medical Corporation
+1 (978) 421-9655


Diane Egan
ZOLL Medical Corporation
+1 (978) 421-9637



French Fire Brigade Purchases 80 ZOLL AutoPulse Units

March 11, 2008—Chelmsford, MASS.—ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of resuscitation devices and related software solutions, announced today that the French Fire Brigade, Service Departmental D’Incendie et de Secours (SDIS 95) of Val d’Oise, France, has contracted with ZOLL to equip all of its rescue vehicles with the AutoPulse® Non-invasive Cardiac Support Pump. The contract represents the largest order to date for AutoPulse in Europe and is worth $1.1 million.

Under the terms of the agreement, SDIS 95 has taken delivery of 34 units, and expects the balance of the order to be placed during calendar year 2008. In early deployments of the CPR device, the fire brigade has reported delivering four sudden cardiac arrest (SCA) patients to the hospital alive.

AutoPulse helps provide the consistent, uninterrupted chest compressions called for by the 2005 American Heart Association and European Resuscitation Council Guidelines. It is an automated, portable device with an easy-to-use, load-distributing LifeBand® that squeezes a wider area of the chest in a consistent, uninterrupted “hands-free” manner, improving blood flow to the heart and brain during cardiac arrest. Additionally, it offers the benefit of freeing up rescuers to focus on other life-saving interventions.

“We’re extremely pleased that this suburban Paris fire department recognizes the importance of delivering consistent, high-quality chest compressions in helping to save the lives of SCA victims,” said Richard A. Packer, President and Chief Executive Officer of ZOLL. “AutoPulse can achieve high levels of circulation to the heart and to the brain because of the unique, consistent chest compressions it generates. It moves more blood more effectively than manual compressions, thereby providing the best possible patient care.”

To date, approximately 2,500 AutoPulse units have been deployed in hospitals and emergency services worldwide.

About Sudden Cardiac Arrest

The human toll from SCA is alarming with more than 1 million deaths occurring annually worldwide. It is the leading cause of unexpected death in the world and strikes without warning. Currently, only about 5 percent of victims survive; 95 percent will die from SCA. SCA is an abrupt disruption of the heart’s function, which causes a lack of blood flow to vital organs.

About SDIS 95

Val d’Oise SDIS 95 is one of 97 fire brigades in France. Located in a northwest suburb of Paris, SDIS 95 serves a metropolitan population of 1.1 million with a fleet of 70 ambulances. It handles an average of 66,000 medical emergencies per year, of which 2.2 percent are cardiac arrests.

About ZOLL Medical Corporation

ZOLL Medical Corporation is committed to developing technologies that help advance the practice of resuscitation. With products for pacing, defibrillation, circulation, ventilation, and fluid resuscitation, ZOLL provides a comprehensive set of technologies, including Real CPR Help® and See Thru CPR™, that help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest or trauma victims. ZOLL also designs and markets software that automates the documentation and management of both clinical and non-clinical information.

ZOLL markets and sells its products in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia. 2008 marks the 25th anniversary of ZOLL’s resuscitation product development. For more information,


Certain statements contained in this press release, including statements regarding the future business of the Company, and other statements contained herein regarding matters that are not historical facts, are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, those factors discussed in the section entitled “Risk Factors” in the Company's Quarterly Report on Form 10-Q filed with the SEC on February 5, 2008. You should not place undue reliance on the forward-looking statements in this press release, and the Company disavows any obligation to update or supplement those statements in the event of any changes in the facts, circumstances, or expectations that underlie those statements

Copyright © 2008 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105. ZOLL, AutoPulse, LifeBand, and Real CPR Help are registered trademarks of ZOLL Medical Corporation. See-Thru CPR is a trademark of ZOLL Medical Corporation. All product names are the property of their respective owners.